Sandoz begins Phase III clinical trial for biosimilar adalimumab
19 December 2013 | By Sandoz
Sandoz advances leading biosimilars pipeline by strengthening Immunology portfolio...
List view / Grid view
19 December 2013 | By Sandoz
Sandoz advances leading biosimilars pipeline by strengthening Immunology portfolio...
24 June 2013 | By Novartis
Sandoz has initiated a major Phase III clinical trial with its biosimilar version of etanercept (Amgen's Enbrel®)...
2 May 2012 | By Novartis
Definitive agreement to acquire Fougera Pharmaceuticals for USD 1.525 billion in an all-cash transaction...